Skip to Content
Merck

Perflubron residua: 12 years following therapy.

Pediatric radiology (2009-02-04)
Sabah Servaes, Monica Epelman
ABSTRACT

Partial liquid ventilation therapy utilizing perfluorocarbons has been used for patients with severe respiratory distress. Perfluorocarbons such as perflubron have been demonstrated to clear from the lungs shortly after therapy. We present a 13-year-old boy with residual perflubron in his lungs, 12 years following therapy with perflubron. The imaging features are important to recognize as these patients return for additional care and imaging.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
1-Bromoheptadecafluorooctane, 99%